Evidence Library

Showing 10 of 182 results.
Ronald Bayer, PhD •
The Trustees of Columbia University of the City of New York
Amy Fairchild, PhD •
The Trustees of Columbia University of the City of New York

In this Perspective for the New England Journal of Medicine the authors compare US and UK approaches to harm reduction, particularly as it applies to e-cigarette policy.

 
Richard Zimmerman, MD, MPH, MA •
University of Pittsburgh Graduate School of Public Health, Center for Public Health Practice
Chyongchiou Jeng Lin, PhD •
University of Pittsburgh

The study, published in the Journal of the National Medical Association, examines the relationship between state laws regulating flu vaccines for health care workers and the state-level immunization rates among health care workers between 2001-2011. Laws mandating flu vaccines for health care workers increase their vaccination rates, according to a new study.

 
Ameet Sarpatwari, JD, PhD •
Brigham and Women’s Hospital Inc.
Aaron Kesselheim, MD, JD, MPH •
Brigham & Women’s Hospital

While prescription drug brand names can increase medication name recognition by patients and help differentiate products, they can also confuse patients and reduce appropriate use of generic drugs. Given increased pressure to reduce drug costs and use medicines safely and effectively, can the prescription drug naming system be improved?

 
Denise Chrysler, JD •
Network for Public Health Law
Michelle Lewis, MD, JD •
Johns Hopkins University

The Legal Toolkit for Newborn Screening DBS provides state legislators and other policy-makers with a menu of options to consider as they develop policies related to the retention and secondary use of residual newborn screening dried blood samples (DBS).

 
Timothy Malloy, JD •
University of California, Los Angeles, School of Law

Regulators are implementing new programs that require manufacturers of products containing certain chemicals of concern to identify, evaluate, and adopt viable, safer alternatives. Such programs raise the difficult question for policymakers and regulated businesses of which alternatives are “viable” and “safer.” To address that question, these programs use “alternatives analysis,” an emerging methodology that integrates issues of human health and environmental effects with technical feasibility and economic impact.

 
Timothy Malloy, JD •
University of California, Los Angeles, School of Law

Emerging "prevention-based" approaches to chemical regulation seek to minimize the use of toxic chemicals by mandating or directly incentivizing the adoption of viable safer alternative chemicals or processes. California and Maine are beginning to implement such programs, requiring manufacturers of consumer products containing certain chemicals of concern to identify and evaluate potential safer alternatives. This article identifies an integrated set of design principles for regulatory alternatives analysis, and illustrates the application of those principles.

 
Lainie Rutkow, JD, PhD •
Johns Hopkins University Bloomberg School of Public Health
Caleb Alexander, MD, MS •
Johns Hopkins University Bloomberg School of Public Health

The study finds Florida’s efforts to prevent inappropriate use of painkillers are showing reductions among prescribers and patients who had the highest prescribing and usage rates.

 
Barbara Dennison, MD •
Health Research Inc./New York State Department of Health

The study reviewed policies from all 129 NY hospitals providing maternity care services. In 2009, none were fully compliant with WHO recommendations, but by 2013, 97, or 75 percent of the hospitals had compliant hospital breastfeeding policies. And as of April 2014, all 129 hospitals in New York had a fully compliant, approved, written breastfeeding policy in place.

 

This Knowledge Asset includes information about the impacts of bullying; the public health framework for anti-bullying laws; the language and content of these laws; and current evaluation studies on the implementation and effectiveness of anti-bullying laws.

 

Pages